Trial intelligence / Profile preview

Terbinafine Nail Bed Deposition via Iontophoresis in Onychomycosis

NCT01484145Phase 2Completed

Sponsor
Nitric BioTherapeutics
Start
Dec 2011
Primary completion
Mar 2012
Modality
Hydrogel Systems, Small Molecules
Countries
1
01

Overview

A Phase 2 trial of Terbinafine subungual gel in onychomycosis, sponsored by Nitric BioTherapeutics. Started Dec 2011; status: completed.

02

Drugs

Terbinafine subungual gel
03

Conditions

onychomycosis

Beyond the preview

Go deeper on NCT01484145.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01484145.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call